Loading cancer entity…
Loading cancer entity…
Clinical trials
185 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04298541 | Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC | withdrawn | Phase 2 | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT06012929 | A Study of ONC201 for Refractory Meningioma | withdrawn | Phase 2 | 0 | University of NebraskaOTHER | 0 | Jan 26, 2026 | clinicaltrials |
| NCT03013387 |
| Dosimetry Guided PRRT With 90Y-DOTATOC |
| withdrawn |
| Phase 2 |
| 0 |
| Sue O'DorisioOTHER |
| 0 |
| Aug 25, 2017 |
| clinicaltrials |
Data updated 22 days agoSource updated Aug 31, 2026source: clinicaltrials